Inhibition of EphB4/ephrinB2, in vitro and in a mouse xenograft model, was associated with an improvement of antitumor responses, particularly when combined with radiotherapy (RT), which resulted in notable reductions in tumor growth in cases of PDAC (145). This evidence concerns the gene EFNB2 and neoplasm.